BRANCH ATHEROMATOUS DISEASE
Clinical trials for BRANCH ATHEROMATOUS DISEASE explained in plain language.
Never miss a new study
Get alerted when new BRANCH ATHEROMATOUS DISEASE trials appear
Sign up with your email to follow new studies for BRANCH ATHEROMATOUS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to stop stroke in its tracks
Disease control CompletedThis study tested whether adding the blood thinner tirofiban to standard aspirin therapy could prevent strokes from getting worse in people with a specific type of small-vessel stroke. About 970 adults aged 18-80 who had a stroke within the previous 48 hours took part. The goal w…
Matched conditions: BRANCH ATHEROMATOUS DISEASE
Phase: PHASE4 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated May 26, 2026 09:01 UTC
-
New drug shows promise for hard-to-treat stroke type
Disease control CompletedThis study tested whether a drug called tirofiban, given through a vein, helps people recover better from a specific type of stroke called branch atheromatous disease (BAD). BAD strokes often get worse quickly and have poor outcomes. The trial involved 516 adults aged 18-75 who h…
Matched conditions: BRANCH ATHEROMATOUS DISEASE
Phase: PHASE3 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 26, 2026 08:35 UTC